Search Results - "Chen, Zinuo"
-
1
Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy
Published in PLoS pathogens (04-08-2022)“…Reporter viruses provide powerful tools for both basic and applied virology studies, however, the creation and exploitation of reporter influenza A viruses…”
Get full text
Journal Article -
2
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
Published in Cell & bioscience (28-02-2021)“…In the urgent campaign to develop therapeutics against SARS-CoV-2, natural products have been an important source of new lead compounds. We herein identified…”
Get full text
Journal Article -
3
Punicalagin is a neuraminidase inhibitor of influenza viruses
Published in Journal of medical virology (01-06-2021)“…Influenza A virus (IAV) causes great morbidity and mortality worldwide every year. However, there are only a limited number of drugs clinically available…”
Get full text
Journal Article -
4
SARS-CoV-2 cell entry and targeted antiviral development
Published in Acta pharmaceutica Sinica. B (01-12-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the pandemic coronavirus disease 2019 (COVID-19), which threatens human…”
Get full text
Journal Article -
5
A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus
Published in Viruses (05-09-2019)“…Influenza A virus infections cause significant morbidity and mortality, and novel antivirals are urgently needed. Influenza RNA-dependent RNA polymerase (RdRp)…”
Get full text
Journal Article -
6
Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology
Published in Animal models and experimental medicine (01-06-2024)“…Background YangshenDingzhi granules (YSDZ) are clinically effective in preventing and treating COVID‐19. The present study elucidates the underlying mechanism…”
Get full text
Journal Article -
7
Combining virus-based affinity ultrafiltration method with serum pharmacochemistry to identify the antiviral pharmacodynamic substances in licorice
Published in Journal of ethnopharmacology (10-02-2025)“…Liorice (Glycyrrhiza uralensis Fisch.), a widely used Chinese herbal medicine, is frequently employed in clinical practice to treat viral pneumonia. However,…”
Get full text
Journal Article -
8
Development of a virus‐based affinity ultrafiltration method for screening virus‐surface‐protein‐targeted compounds from complex matrixes: Herbal medicines as a case study
Published in Journal of medical virology (01-03-2024)“…Herbal medicines (HMs) are one of the main sources for the development of lead antiviral compounds. However, due to the complex composition of HMs, the…”
Get full text
Journal Article -
9
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro
Published in Antiviral research (01-06-2021)“…The emerging SARS-CoV-2 infection is the cause of the global COVID-19 pandemic. To date, there are limited therapeutic options available to fight this disease…”
Get full text
Journal Article -
10
Licochalcone A plays dual antiviral roles by inhibiting RSV and protecting against host damage
Published in Journal of medical virology (01-08-2023)“…Respiratory syncytial virus (RSV) causes lower respiratory tract diseases and bronchiolitis in children and elderly individuals. There are no effective drugs…”
Get full text
Journal Article -
11
Revisiting influenza A virus life cycle from a perspective of genome balance
Published in Virologica Sinica (01-02-2023)“…Influenza A virus (IAV) genome comprises eight negative-sense RNA segments, of which the replication is well orchestrated and the delicate balance of multiple…”
Get full text
Journal Article -
12
Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2
Published in Journal of medical virology (01-03-2023)“…The ongoing pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has posed a major public…”
Get full text
Journal Article -
13
Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor
Published in Virologica Sinica (01-12-2023)“…Influenza A virus (IAV) poses a global public health concern and remains an imminent threat to human health. Emerging antiviral resistance to the currently…”
Get full text
Journal Article -
14
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL pro
Published in Antiviral research (01-06-2021)“…The emerging SARS-CoV-2 infection is the cause of the global COVID-19 pandemic. To date, there are limited therapeutic options available to fight this disease…”
Get full text
Journal Article